Clinical trial
Efficacy and Safety of Cilostazol for the Indication of CSPS
NCT00216749 · Korea Otsuka Pharmaceutical Co., Ltd., Industry · Completed
Key facts
| NCT number | NCT00216749 |
|---|---|
| Title | Efficacy and Safety of Cilostazol for the Indication of CSPS |
| Official title | Post Marketing Surveillance of Efficacy and Safety of Cilostazol for the Indication of CSPS |
| Lead sponsor | Korea Otsuka Pharmaceutical Co., Ltd., Industry |
| Status | Completed |
| Study type | Observational |
| Conditions | Cerebral Infarction |
| Enrollment | 650 |
| Start date | Dec 1, 2003 |
| Primary completion | Oct 1, 2007 |
| Completion | Oct 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | Dec 17, 2009 |
| Countries | South Korea |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: